Form 4 for HCA HCA Healthcare
Accepted 2023-02-07 00:00:00 ET · period of report 2023-02-03 · accession 0001209191-23-007674 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-07 | 2023-02-03 | HCA | HAZEN SAMUEL N | CEO, Dir | F - Tax | $258.08 | -32.2K | 105.7K | -23% | -$8.31M |
| D | 2023-02-07 | 2023-02-03 | HCA | HAZEN SAMUEL N | CEO, Dir | M - OptEx | $68.96 | +59.0K | 137.9K | +75% | +$4.07M |
| D | 2023-02-07 | 2023-02-03 | HCA | HAZEN SAMUEL N | CEO, Dir | M - OptEx | $0.00 | -59.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-03 | F | D | 32,208 | $258.08 | 105,677 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-03 | M | A | 59,000 | $68.96 | 137,885 | D | — | — | |
| 3 | Derivative | Stock Appreciation Right | 2023-02-03 | M | D | 59,000 | $0.00 | 0 | D | $68.96 · — to 2025-02-04 | 59,000 Common Stock | (F1) The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. |